Product Code: ETC089514 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The antiparasitics drugs market in Australia is witnessing steady growth driven by the increasing prevalence of parasitic infections, zoonotic diseases, and veterinary healthcare services. Antiparasitics drugs are medications used to treat parasitic infestations in humans and animals, including protozoa, helminths, and ectoparasites. They are used in the prevention and control of diseases such as malaria, schistosomiasis, and Lyme disease, as well as in the treatment of livestock and companion animals affected by worms, ticks, and fleas. With the growing globalization of trade and travel, climate change, and changes in land use, there is a rising need for effective antiparasitics drugs that offer broad-spectrum activity, safety, and affordability in the Australia market. Key players in the market are offering a wide range of antiparasitics formulations, veterinary medicines, and diagnostic tests to help healthcare providers and animal owners combat parasitic infections and improve animal welfare.
The Australia Antiparasitics Drugs Market experiences growth driven by factors such as the prevalence of parasitic infections in animals and humans, veterinary healthcare practices, and advancements in drug development for parasitic diseases. Additionally, factors like animal husbandry practices, regulatory frameworks for veterinary medicines, and public health initiatives contribute to market expansion and investment in antiparasitic therapies.
Challenges in the Australia antiparasitic drugs market include drug resistance, animal welfare concerns, and regulatory requirements. Antiparasitic drugs are essential for controlling parasitic infections in livestock and companion animals. However, combating drug-resistant parasites, addressing ethical considerations related to animal treatment, and navigating regulatory approval processes pose challenges for antiparasitic drug manufacturers and veterinarians in Australia.
In the Australia antiparasitics drugs market, government regulations focus on drug safety, efficacy, and veterinary use. Standards may cover drug registration requirements, labeling specifications, and pharmacovigilance measures to ensure the quality and effectiveness of antiparasitic medications for animal use. Additionally, regulations may address issues such as dosage recommendations, withdrawal periods, and residue limits to protect animal health and food safety. Government agencies provide oversight, review services, and regulatory enforcement to pharmaceutical manufacturers, veterinarians, and animal owners to ensure compliance with antiparasitics drugs regulations and support animal welfare efforts in Australia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Antiparasitics Drugs Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Antiparasitics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Australia Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Australia Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Australia Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Australia Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership rates in Australia |
4.2.2 Growing awareness about the importance of parasite prevention in pets |
4.2.3 Rising disposable income leading to higher spending on pet healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulations and approvals required for antiparasitic drugs |
4.3.2 Competition from alternative parasite prevention methods such as natural remedies |
4.3.3 Potential side effects associated with antiparasitic drugs leading to safety concerns |
5 Australia Antiparasitics Drugs Market Trends |
6 Australia Antiparasitics Drugs Market, By Types |
6.1 Australia Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Australia Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2021-2031F |
6.1.3 Australia Antiparasitics Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.1.4 Australia Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2021-2031F |
6.1.5 Australia Antiparasitics Drugs Market Revenues & Volume, By Topical, 2021-2031F |
6.2 Australia Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Australia Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2021-2031F |
6.2.3 Australia Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2021-2031F |
6.2.4 Australia Antiparasitics Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.3 Australia Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Australia Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Australia Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Australia Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Australia Antiparasitics Drugs Market Export to Major Countries |
7.2 Australia Antiparasitics Drugs Market Imports from Major Countries |
8 Australia Antiparasitics Drugs Market Key Performance Indicators |
8.1 Number of veterinary clinics offering antiparasitic drugs |
8.2 Percentage of pet owners following recommended parasite prevention guidelines |
8.3 Frequency of antiparasitic treatments administered to pets |
9 Australia Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Australia Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Australia Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Australia Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Antiparasitics Drugs Market - Competitive Landscape |
10.1 Australia Antiparasitics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Australia Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |